Network origin in Charles Richter King first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
27
| Subsidiary | Pharmaceuticals: Major | 27 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Charles Richter King via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Diacrin, Inc. (Delaware)
 Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE. | Medical Specialties | Director/Board Member President Director/Board Member Corporate Officer/Principal Director/Board Member | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Sales & Marketing Director/Board Member Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| NOVAVAX, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO General Counsel | |
| The Johns Hopkins University | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
Celldex Research Corp.
 Celldex Research Corp. Miscellaneous Commercial ServicesCommercial Services Celldex Research Corp. engages in provision of biological research and development. The company is headquartered in Phillipsburg, NJ. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Duke University Medical Center | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| CELLDEX THERAPEUTICS, INC. | Medical/Nursing Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Pittsburgh | College/University | Doctorate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| POLYMEDIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Doctorate Degree Undergraduate Degree | |
Alba Therapeutics Corp.
 Alba Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman | |
| VERNALIS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
National Marrow Donor Program
 National Marrow Donor Program Miscellaneous Commercial ServicesCommercial Services Part of The Marrow Foundation, National Marrow Donor Program is a company that provides treatments for those facing life-threatening blood cancers. The company is based in Minneapolis, MN. The CEO of the company is Amy L. Ronneberg. | Miscellaneous Commercial Services | Director/Board Member | |
Instrumentation Laboratory Co.
 Instrumentation Laboratory Co. Medical SpecialtiesHealth Technology Instrumentation Laboratory Co. manufactures diagnostic products. It offers critical care systems, hemostatis products and information management services. The firm provides services to the hospitals and clinical laboratories. Instrumentation Laboratory was founded in 1959 and is headquartered in Bedford, MA. | Medical Specialties | President | |
| BIOGEN INC. | Pharmaceuticals: Major | Chairman | |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Investment Banks/Brokers | Director/Board Member | |
| IMUNON, INC. | Biotechnology | Director of Finance/CFO | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
Cellzome, Inc.
 Cellzome, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Cellzome, Inc. develops immune-inflammation therapy. The company is based in Philadelphia, PA. The company was founded by Spyridon Artavanis-Tsakonas, Stelios Papadopoulos. | Pharmaceuticals: Major | Founder | |
Meridian Medical Technologies LLC
 Meridian Medical Technologies LLC Medical SpecialtiesHealth Technology Meridian Medical Technologies LLC develops auto injectors for the pharmaceutical and biotechnological industries. Its product Antidote Treatment Nerve Agent, Auto-Injector is intended as an initial treatment of the symptoms of organophosphorous nerve agent poisoning; additional medical care should be sought as soon as possible. The company was founded in 1968 and is headquartered in Columbia, MD. | Medical Specialties | Director of Finance/CFO | |
| DOMINARI HOLDINGS INC. | Biotechnology | Director of Finance/CFO | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Director/Board Member | |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Pharmaceuticals: Major | Chairman | |
| EUCRATES BIOMEDICAL ACQUISITION CORP. | Financial Conglomerates | Founder | |
The BioExec Institute, Inc.
 The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The BioExec Institute, Inc. is a network of executives in the life sciences industry. The private company is based in Cambridge, MA. The company was founded in 2004 by Hoda Jeanne Abou-Jamra. Hoda Jeanne Abou-Jamra has been the CEO since 2004. | Miscellaneous Commercial Services | Director/Board Member | |
Cellzome Ltd.
 Cellzome Ltd. Pharmaceuticals: MajorHealth Technology Cellzome Ltd. engages in the research, development, and manufacture of pharmaceutical products. It provides kinase-targeted drugs to treat inflammatory diseases. The company was founded by Gitte Neubauer on December 22, 2003 and is headquartered in Middlesex, the United Kingdom. | Pharmaceuticals: Major | Founder | |
Rho Capital Partners, Inc.
 Rho Capital Partners, Inc. Investment ManagersFinance Rho Capital Partners, Inc. (Rho Capital Partners) is a venture capital firm founded in 1981 by Joshua Ruch. The firm is headquartered in New York. | Investment Managers | Founder | |
| Brandeis University | College/University | Corporate Officer/Principal | |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Investment Managers | President | |
| University of Florida | College/University | Doctorate Degree | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| INTERMUNE INC | Biotechnology | Director/Board Member | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
| Kenyon College | College/University | Undergraduate Degree |
Statistics
International
| United States | 47 |
| United Kingdom | 3 |
| New Zealand | 2 |
| Germany | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 11 |
| Finance | 7 |
| Commercial Services | 5 |
| Process Industries | 3 |
Operational
| Director/Board Member | 142 |
| Corporate Officer/Principal | 55 |
| Independent Dir/Board Member | 31 |
| Chairman | 30 |
| Chief Tech/Sci/R&D Officer | 27 |
Most connected contacts
| Insiders | |
|---|---|
| Joshua Ruch | 33 |
| Stelios Papadopoulos | 26 |
| William N. Kelley | 22 |
| Barbara Hackman Franklin | 22 |
| Wayne T. Hockmeyer | 22 |
| Herbert Conrad | 21 |
| Hal R. Werner | 17 |
| Zola P. Horovitz | 15 |
| Henrik Rasmussen | 14 |
| Douglas Swirsky | 14 |
| Marc R. Schneebaum | 13 |
| Michael Taylor | 12 |
| David P. Wright | 9 |
| Grant Yonehiro | 9 |
| Thomas Andrew Davis | 9 |
- Stock Market
- Insiders
- Charles Richter King
- Company connections
